Skip to main content

Study finds three strains of resistant bacteria, identifying greater diversity

May 14, 2020

    A new study by the Multi-Drug-Resistant Organism Network of the Antibacterial Resistance Leadership Group (ARLG) has found that strains of carbapenem-resistant enterobacterales (CRE), a major threat to vulnerable patient populations, are more diverse than previously thought. The MDRO Network is led by UNC Infectious Diseases investigator David van Duin, MD, PhD. Analyzing patient … Read more

Schranz receives NIH grant to study patient care for drug-use related heart infections

May 6, 2020

Asher Schranz, MD, MPH, assistant professor of medicine in the division of infectious diseases, has received a grant from the NIH National Institute on Drug Abuse for the project “Drug-use associated infective endocarditis: Post-hospitalization outcomes and patient treatment preferences.” Schranz’s research is broadly focused on the intersection of infectious diseases and substance use disorders. He … Read more

Pay-it-forward model increases STI testing and community health

April 27, 2020

Watch animation video explaining UNC Project-China’s STI pay-it-forward study. Gonorrhea and chlamydia are two common sexually transmitted infections (STIs) that increase HIV risk among many key populations, including gay and bisexual men. But most men are not tested for STIs, in part because of the cost and low community engagement. A new study from researchers … Read more

Study addresses COVID-19 infection rates for household members

April 24, 2020

By Alyssa LaFaro As seven states now require masks and face coverings for visiting essential businesses or using public transportation, it seems like those spaces are where we are most at risk for COVID-19 infection. But, in truth, the riskiest place could be our homes — at least, if you live with someone who tests positive for the … Read more

Faculty affiliates turn focus to COVID-19 treatments, prevention research

April 6, 2020

  Researchers within UNC’s School of Medicine are working tirelessly to provide knowledge to impact the current COVID-19 pandemic and future pandemics. “UNC SOM is home to many world-renowned experts on infectious disease and virology,” says Blossom Damania, Boshamer Distinguished Professor and Vice Dean for Research at the UNC School of Medicine. “We are very … Read more

Researchers receive up to $10.7 million to study chlamydia vaccine

May 30, 2019

  Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the U.S., Europe and Australia, will receive up to $10.7 million over five years from … Read more